Real Time Three Dimensional Transesophageal Echocardiography for Guidance of Catheter Based Interventions

  • Miguel Angel Garcia Fernandez
  • Gila Perk
  • Muhamed Saric
  • Itzhak Kronzon
Chapter
First Online:

Abstract

Over the recent years, percutaneous catheter-based intracardiac procedures have gained growing acceptance into the cardiac procedural armamentarium allowing treatment of increasingly complex cardiac pathologies via a non surgical, catheter based approach. 1–6 Guidance of these procedures is usually by fluoroscopy. However, this technique has limited resolution for soft tissue differentiation, and involves radiation exposure as well as occasional iodinated contrast injection. Other guiding techniques include intracardiac echocardiography or transesophageal 2DE.7–14 Intracardiac echocardiography is a useful, yet invasive and expensive technique. The disposable ultrasound catheter is inserted via a central venous approach and is for single-use only. Additionally, intracardiac echocardiography transducers are limited monoplane transducers and allow only several imaging planes. Transesophageal 2DE is commonly used for guiding purposes, however it has several limitations. The main limitation of transesophageal 2DE is related to the tomographic nature of this imaging technique. Since only a “slice” of the heart is imaged at any given view, intra-cardiac catheters cannot be fully visualized without acquisition from multiple imaging planes, which may be time consuming and distracting during a procedure. The relative location of an intra-cardiac catheter and the surrounding anatomical structures can be challenging with a two-dimensional tomographic view, especially for the interventionalist who may be less familiar with the various transesophageal echocardiographic planes.

Keywords

Atrial Septal Defect Ventricular Septal Defect Left Atrial Appendage Color Doppler Imaging Interatrial Septum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hung JS, Chern MS, Wu JJ, Fu M, Yeh KH, Wu YC, et al. Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol. 1991;67:854–862.CrossRefPubMedGoogle Scholar
  2. 2.
    Arora R, Kalra GS, Singh S, Mukhopadhyay S, Kumar A, Mohan JC, et al. Percutaneous transvenous mitral commissurotomy: immediate and long-term follow-up results. Catheter Cardiovasc Interv. 2002;55:450–456.CrossRefPubMedGoogle Scholar
  3. 3.
    Masura J, Gavora P, Pondar T. Long term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol. 2005;45:505–507.CrossRefPubMedGoogle Scholar
  4. 4.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, et al. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Am Heart J. 2008;56:356–360.CrossRefGoogle Scholar
  5. 5.
    Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, et al. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study. Catheter Cardiovasc Interv. 2008:71:822–828.CrossRefPubMedGoogle Scholar
  6. 6.
    Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105:1887–1889.CrossRefPubMedGoogle Scholar
  7. 7.
    Hung JS, Fu M, Yeh KH, Wu CJ, Wong P. Usefulness of intracardiac echocardiography in complex transseptal catheterization during percutaneous transvenous mitral commissurotomy. Mayo Clin Proc. 1996;71:134–140.CrossRefPubMedGoogle Scholar
  8. 8.
    Zanchetta M. On-line intracardiac echocardiography alone for Amplatzer Septal Occluder selection and device deployment in adult patients with atrial septal defect. Int J Cardiol. 2004;95:61–68.CrossRefPubMedGoogle Scholar
  9. 9.
    Kronzon I, Tunick PA, Schwinger ME, Slater J, Glassman E. Transesophageal echocardiography during percutaneous mitral valvuloplasty. J Am Soc Echocardiogr. 1989;2:380–385.PubMedGoogle Scholar
  10. 10.
    Kronzon I, Tunick PA, Glassman E, Slater J, Schwinger M, Freedberg RS. Transesophageal echocardiography to detect atrial clots in candidates for percutaneous transseptal mitral balloon valvuloplasty. J Am Coll Cardiol. 1990;16:1320–1322.CrossRefPubMedGoogle Scholar
  11. 11.
    Vilacosta I, Iturralde E, San Román JA, Gómez-Recio M, Romero C, Jiménez J, et al. Transesophageal echocardiographic monitoring of percutaneous mitral balloon valvulotomy. Am J Cardiol. 1992; 70:1040–1044.CrossRefPubMedGoogle Scholar
  12. 12.
    Goldstein SA, Campbell A, Mintz GS, Pichard A, Leon M, Lindsay J Jr. Feasibility of on-line transesophageal echocardiography during balloon mitral valvulotomy: experience with 93 patients. J Heart Valve Dis. 1994;3:136–148.PubMedGoogle Scholar
  13. 13.
    Applebaum RM, Kasliwal RR, Kanojia A, Seth A, Bhandari S, Trehan N, et al. Utility of three-dimensional echocardiography during balloon mitral valvuloplasty. J Am Coll Cardiol. 1998;32:1405–1409.CrossRefPubMedGoogle Scholar
  14. 14.
    Mazic U, Gavora P, Masura J. The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder. Am Heart J. 2001;142:482–488.CrossRefPubMedGoogle Scholar
  15. 15.
    Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv. 2001;53:386–391.CrossRefPubMedGoogle Scholar
  16. 16.
    Acar P, Saliba Z, Bonhoeffer P, Aggoun Y, Bonnet D, Sidi D, et al. Influence of atrial septal defect anatomy in patient selection and assessment of closure with the Cardioseal device; a three-dimensional transesophageal echocardiographic reconstruction. Eur Heart J. 2000;21:573–581.CrossRefPubMedGoogle Scholar
  17. 17.
    Halpern DG, Perk G, Ruiz C, Marino N, Kronzon I. Percutaneous closure of a post-myocardial infarction ventricular septal defect guided by real-time three-dimensional echocardiography. Eur J Echocardiogr. 2009; doi: 10.1093/ejechocard/jep021.Google Scholar
  18. 18.
    Mullasari AS, Umesan CV, Krishnan U, Srinivasan S, Rvikumar M, Raghuraman H. Transcatheter closure of post-myocardial infarction ventricular septal defect with Amplatzer septal occluder. Catheter Cardiovasc Interv. 2001;54:484–487.CrossRefPubMedGoogle Scholar
  19. 19.
    Holzer R, Balzer D, Amin Z, Ruiz C, Feinstein J, Bass J, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: results of a U.S. Registry. Catheter Cardiovasc Interv. 2004;61:196–201.CrossRefPubMedGoogle Scholar
  20. 20.
    Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134–2140.CrossRefPubMedGoogle Scholar
  21. 21.
    Herrmann HC, Rohatgi S, Wasserman HS, Block P, Gray W, Hamilton A, et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv. 2006;68:821–828.CrossRefPubMedGoogle Scholar
  22. 22.
    Sugeng L, Shernan SK, Weinert L, Shook D, Raman J, Jeevanandam V, et al. Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr. 2008;21:1347–1354.CrossRefPubMedGoogle Scholar
  23. 23.
    Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation. 1996;94:2124–2130.PubMedGoogle Scholar
  24. 24.
    Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines or the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and The Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1–148.CrossRefPubMedGoogle Scholar
  25. 25.
    Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol. 1993;21:390–397.CrossRefPubMedGoogle Scholar
  26. 26.
    Messika-Zeitoun D, Blanc J, Iung B, et al. Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. J Am Coll Cardiol Img. 2009;2:1–7.Google Scholar
  27. 27.
    Gill EA, Kim MS, Carroll JD 3D TEE for evaluation of commissural opening before and during percutaneous mitral commissurotomy. J Am Coll Cardiol Img, 2009;2:1034–1035.Google Scholar
  28. 28.
    Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–1158.CrossRefPubMedGoogle Scholar
  29. 29.
    Rothlin ME, Egloff L, Kugelmeier J, Turina M, Senning A. Reoperations after valvular heart surgery: indications and late results. Thorac Cardiovasc Surg. 1980;28:71–76.CrossRefPubMedGoogle Scholar
  30. 30.
    Genoni M, Franzen D, Vogt P et al. Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg. 2000;17:14–19.CrossRefPubMedGoogle Scholar
  31. 31.
    Pate G, Webb J, Thompson C et al. Percutaneous closure of a complex prosthetic mitral paravalvular leak using transesophageal echocardiographic guidance. Can J Cardiol. 2004;20:452–455.PubMedGoogle Scholar
  32. 32.
    Moneta A, Villa E, Donatelli F. An alternative technique for non-infective paraprosthetic leakage repair. Eur J Cardiothorac Surg. 2003;23:1074–1075.CrossRefPubMedGoogle Scholar
  33. 33.
    Jindani A, Neville EM, Venn G, Williams BT. Paraprosthetic leak: a complication of cardiac valve replacement. J Cardiovasc Surg (Torino) 1991;32:503–508.Google Scholar
  34. 34.
    Hourihan M, Perry SB, Mandell VS et al. Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol. 1992;20:1371–1377.CrossRefPubMedGoogle Scholar
  35. 35.
    Moscucci M, Deeb GM, Bach D, Eagle KA, Williams DM. Coil embolization of a periprosthetic mitral valve leak associated with severe hemolytic anemia. Circulation. 2001;104:E85–E86.CrossRefPubMedGoogle Scholar
  36. 36.
    Cortes M, Garcia E, Garcia-Fernandez MA, Gomez JJ, Perez-David E, Fernandez F. Usefulness of transesophageal echocardiography in percutaneous transcatheter repairs of paravalvular mitral regurgitation. Am J Cardiol. 2008;101:382–386.CrossRefPubMedGoogle Scholar
  37. 37.
    Perk G, Lang RM, Garcia-Fernandez MA, Lodato J, Sugeng L, Lopez J, Knight BP, Messika-Zeitoun D, Shah S, Slater J, Brochet E, Varkey M, Hijazi Z, Marino N, Ruiz C, Kronzon I. Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions. J Am Soc Echocardiogr. 2009;22(8):865–882.PubMedGoogle Scholar
  38. 38.
    Kronzon I, Sugeng L, Perk G, Hirsh D, Weinert L, Garcia Fernandez MA, Lang RM. Real-time 3-dimensional transesophageal echocardiography in the evaluation of post-operative mitral annuloplasty ring and prosthetic valve dehiscence. J Am Coll Cardiol. 2009;53(17):1543–1547.CrossRefPubMedGoogle Scholar
  39. 39.
    Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–1225.CrossRefPubMedGoogle Scholar
  40. 40.
    Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression and treatment strategies. Circulation. 2005;111:3316–3326.CrossRefPubMedGoogle Scholar
  41. 41.
    Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Guidelines on the management of valvular heart disease. Eur Heart J. 2007;28:230–268.Google Scholar
  42. 42.
    Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763.CrossRefPubMedGoogle Scholar
  43. 43.
    Zajarias, MD A G, Cribier, MD Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009;53:1829–1836.CrossRefPubMedGoogle Scholar
  44. 44.
    Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified aortic valves with a valved stent? Results from a human anatomical study in adults. J Am Coll Cardiol. 2008;51:579–584.CrossRefPubMedGoogle Scholar
  45. 45.
    García-Fernández MA, Pérez-David E, Quiles J, Peralta J, García-Rojas I, Bermejo J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42:1253–1258.CrossRefPubMedGoogle Scholar
  46. 46.
    Crystal E, Lamy A, Connolly SJ, Kleine P, Hohnloser SH, Semelhago L, et al; Left Atrial Appendage Occlusion Study. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. Am Heart J. 2003;145:174–178.CrossRefPubMedGoogle Scholar
  47. 47.
    Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol. 2003;42:1249–1252.CrossRefPubMedGoogle Scholar
  48. 48.
    Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49:1490–1495.CrossRefPubMedGoogle Scholar
  49. 49.
    Möbius-Winkler S, Schuler GC, Sick PB. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Curr Opin Neurol. 2008;21:64–69. Review.CrossRefPubMedGoogle Scholar
  50. 50.
    Hanna IR, Kolm P, Martin R, Reisman M, Gray W, Block PC. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J Am Coll Cardiol. 2004;43:1868–1872.CrossRefPubMedGoogle Scholar
  51. 51.
    Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46:9–14.CrossRefPubMedGoogle Scholar
  52. 52.
    Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469–473.CrossRefPubMedGoogle Scholar
  53. 53.
    Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Herat study. Circulation. 1998;98:946–952.PubMedGoogle Scholar
  54. 54.
    Haissaguerre M, Gencel L, Fischer B, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1994;5:1045–1052.CrossRefPubMedGoogle Scholar
  55. 55.
    Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary veins ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000;102:2619–2628.PubMedGoogle Scholar
  56. 56.
    Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2007;4:816–861.CrossRefPubMedGoogle Scholar
  57. 57.
    Chierchia G, Van Camp G, Sarkozy A, Asmundis C, Brugada P Double transseptal puncture guided by real-time three-dimensional transesophageal echocardiography during atrial fibrillation ablation. Europace. 2008;10:705–706.CrossRefPubMedGoogle Scholar
  58. 58.
    Yang H, Srivathsan K, Wissner E, Chandrasekaran K. Atrial fibrillation ablation with a prosthetic mitral valve real-time 3-dimensional transesophageal echocardiography: novel utility. Circulation. 2008;117;e304–e305.Google Scholar
  59. 59.
    Balzer J, Kuhl H, Rassaf T, Hoffman R, Schauerte P, Kelm M, et al. Real-time transesophageal three-dimensional echocardiography for guidance of percutaneous cardiac interventions: first experience. Clin Res Cardiol 2008; [Epub ahead of print].Google Scholar

Copyright information

© Springer London 2010

Authors and Affiliations

  • Miguel Angel Garcia Fernandez
  • Gila Perk
  • Muhamed Saric
  • Itzhak Kronzon
    • 1
  1. 1.NYU School of MedicineNew YorkUSA

Personalised recommendations